Trading indicator
Money Flow IndexBacktest results
| Position | Trades | Duration | Win rate | Win/loss | Avg win | Avg loss | Return |
| Long | 10 | 4.5 | 20% | 25% | 1.6% | -0.8% | -3.4% |
|---|---|---|---|---|---|---|---|
| Short | 5 | 4.2 | 40% | 67% | 1.9% | -3.2% | -5.9% |
Company
Indicator
| Code | Company | Date | Close | Change | Indicator | Value | Signal |
|---|
Trading Performance
Money Flow Index
Score
-2.25
| Position | Trades | Duration | Win Rate | Win/Loss | Avg Win | Avg Loss | Return |
|---|---|---|---|---|---|---|---|
| SHORT | 2 | 244.5 | 0.50% | 1.00% | 112.7% | -55.6% | 57.1% |
| LONG | 2 | 70.5 | 0.00% | 0.00% | 0.0% | -42.0% | -84.1% |
Summary
Technical Analysis
Impedimed (IPD.AX)
Indicator:
MONEY FLOW INDEX
Last Signal:
NEUTRAL
Trading: NO POSITION
Signal Strength: MEDIUM
Money Flow Index (MFI) is a volume-based indicator it could be used in technical analysis to measure the strength of money flow in and out of a security index and market. The principle of MFI calculation is a comparison of positive money flow to negative money flow. MFI is also known as volume-weighted RSI. MFI starts with the typical price for each period. The same as RSI the MFI scale is between 0 and 100.
Calculation: Money Flow Index (MFI):
1) Typical Price = (High + Low + Close)/3;
2) Raw Money Flow = Typical Price x Volume;
3) Money Flow Ratio = (14-period Positive Money Flow)/(14-period Negative Money Flow);
4) Money Flow Index = 100 - 100/(1 + Money Flow Ratio)
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
Top 10:
Money Flow Index
| Company | Close | Change(%) | Volume | Value | Signal |
|---|---|---|---|---|---|
| SIQ Smartgroup | 11 | 21.7 | 2,435,618 | 71.71 | NEUTRAL |
| URF Us Masters Residential Property Fund | 0.85 | 18.1 | 636,687 | 53.73 | NEUTRAL |
| GSW Getswift | 0.28 | 12 | 1,005,626 | 48.64 | NEUTRAL |
| LLC Lend Lease Corporation | 15.01 | 10.9 | 5,153,464 | 43.57 | NEUTRAL |
| BPT Beach Petroleum | 2 | 10.8 | 15,230,683 | 41.72 | NEUTRAL |
| JIN Jin | 18.86 | 10.2 | 1,202,465 | 43.28 | NEUTRAL |
| IMD Imdex | 1.3 | 7.9 | 4,121,418 | 40.92 | NEUTRAL |
| IRD Iron Road | 0.06 | 6.9 | 10,000 | 46.1 | NEUTRAL |
| KGN Kogan | 5.24 | 6.5 | 445,750 | 53.79 | NEUTRAL |
| APX Appen | 24.52 | 6.4 | 826,568 | 29.67 | NEUTRAL |